Summary & Overview
HCPCS Q0081: Infusion Therapy, Non-Chemotherapeutic, Per Visit
HCPCS Level II code Q0081 designates infusion therapy for administration of drugs other than chemotherapeutic agents, billed on a per-visit basis. This code is used across outpatient settings where patients receive intravenous or other infused non-oncology medications and is relevant to facility and professional billing for infusion services. Nationally, non-chemotherapy infusions represent a significant component of outpatient care for chronic and acute conditions managed with biologics, monoclonal antibodies, immunotherapies, and supportive medications.
Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for infusion visits, common payer coverage considerations, and operational benchmarks when available. The publication highlights coding intent, typical sites of service, and the administrative role of per-visit billing for infusion therapy. It will also summarize common modifiers and areas where policy updates or clarification are frequently sought. Where input data is not provided, the report notes that information is not available in the input.
Billing Code Overview
HCPCS Level II code Q0081 describes infusion therapy using non-chemotherapeutic drugs, billed per visit. The service type is infusion therapy for administration of medications other than chemotherapeutic agents. The typical site of service is outpatient infusion settings such as hospital outpatient departments, infusion centers, physician offices, or other ambulatory care settings where medication is administered by clinical staff on a per-visit basis.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with chronic iron-deficiency anemia presents to an outpatient infusion center for parenteral iron therapy. The patient has oral iron intolerance and prior inadequate response to oral supplementation. A registered nurse performs pre-infusion vitals and verifies indication, medication, and consent. The clinician orders an infusion of an FDA-approved non-chemotherapeutic agent (for example, intravenous iron sucrose or ferric carboxymaltose). The infusion visit includes medication preparation by pharmacy, administration via peripheral IV or existing vascular access, continuous monitoring for infusion reactions, and post-infusion observation for 30–60 minutes. Documentation includes start and stop times, total medication administered, patient tolerance, any medications administered for adverse reactions, and discharge instructions. Billing for the visit uses HCPCS Level II code Q0081 to report infusion therapy using non-chemotherapeutic drugs per visit, with applicable modifier appended when indicated to reflect professional component, unusual circumstances, or multiple procedures during the same encounter.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier / default | Rarely reported separately; some payors require no modifier field when no special circumstance applies |